Celebrating 79 Years of Fighting Cancer: A Look at INCan's Impact
For nearly eight decades, Mexico's National Institute of Cancerology (INCan) has been at the forefront of the fight against cancer. This year marks their 79th anniversary, a significant milestone that highlights their enduring commitment to patient care, research, and training. But what does this mean for the future of cancer treatment in Mexico? Let's dive in.
INCan isn't just any cancer center; it treats approximately 7% of all cancer cases nationwide. Over the past few years, they've seen remarkable growth, especially in treating breast, prostate, and cervical cancers. This growth has been accompanied by advancements in precision treatment and strengthened partnerships with academic institutions.
Director General Óscar Arrieta emphasizes that this anniversary is a responsibility to continue the legacy of providing care, conducting research, and training specialists to strengthen the country's fight against cancer. The institute's focus remains on improving access to care, modernizing equipment, and integrating innovations to improve clinical decision-making and patient outcomes.
Impressive Growth in Cancer Care
Between 2018 and 2024, INCan reported significant increases in specific cancer treatments:
- Breast cancer care grew by 146%.
- Prostate cancer cases increased by 89%.
- Cervical cancer cases rose by 56%.
These numbers reflect the growing need for specialized care and INCan's role as a high-complexity center. In 2024 alone, INCan provided 318,000 consultations across various oncology disciplines.
Facing Rising Demand
With demand on the rise, INCan anticipates over 8,300 new patients in 2025. This increase underscores the need for early detection programs and rapid-reference pathways, especially for cancers with high mortality rates when diagnosed late. Gabriela Torres, a researcher from the National Institute of Public Health (INSP), stresses the importance of early detection and timely treatment. She suggests that at least 60% of cases should be identified in the early stages, with no more than 60 days passing between a patient's first visit and a diagnosis. This approach is essential for survival and ensuring comprehensive care.
Technological Advancements
INCan is committed to modernizing its facilities. Recent additions include:
- Stereotactic radiosurgery and radiotherapy (October), particularly for skin cancer and cutaneous lesions, allowing for high-precision treatment.
- Robotic surgery equipment (August 2024), expanding minimally invasive options.
These investments aim to reduce hospital stays, complications, and treatment toxicity. Future plans include upgrades to PET-CT scanners and other imaging equipment.
Training and Research
Academic training remains a core function of INCan, with 68 active agreements with national and international universities. They have 55 agreements for undergraduate training, with 210 students enrolled, and 13 at the postgraduate level, supporting over 450 medical residents. INCan emphasizes the importance of linking laboratory research with clinical operations to develop diagnostic tools, targeted therapies, and prevention strategies.
Free Access to Care
Since 2022, INCan has operated under a gratuity model, covering surgery, radiotherapy, and medications, including targeted therapies, molecular studies, and immunotherapy. This model aims to reduce financial barriers and improve care continuity. The institute is also expanding supportive services like mental health, nutrition, and rehabilitation.
Prevention and Screening
Prevention and screening are central to INCan's long-term strategy. The DETECTO program, which uses low-dose CT scanning for early lung cancer detection, has shown promising results. It has become a regional benchmark for screening initiatives in Latin America.
Looking Ahead
INCan plans to broaden access to innovative medications, expand radiotherapy infrastructure, and integrate digital technologies to improve diagnostic precision and patient comfort. They are also evaluating ways to manage growing patient volumes and ensure timely access to specialized care.
Controversy & Comment Hooks:
Is INCan's model of free care sustainable in the long term? What are the potential challenges and benefits of such a system? Share your thoughts in the comments below! And, do you think the focus on early detection is the right approach, or should more resources be allocated to advanced treatments? We'd love to hear your opinions.
